We are live on ! Find out more
MBOT icon

Microbot Medical
MBOT

70 hedge funds and large institutions have $22.8M invested in Microbot Medical in 2025 Q4 according to their latest regulatory filings, with 19 funds opening new positions, 17 increasing their positions, 15 reducing their positions, and 13 closing their positions.

New
Increased
Maintained
Reduced
Closed

96% more call options, than puts

Call options by funds: $1.94M | Put options by funds: $991K

46% more first-time investments, than exits

New positions opened: 19 | Existing positions closed: 13

13% more repeat investments, than reductions

Existing positions increased: 17 | Existing positions reduced: 15

4% more funds holding

Funds holding: 67 → 70 (+3)

0.02% less ownership

Funds ownership: 16.98% → 16.96% (-0.02%)

17% less capital invested

Capital invested by funds: $27.4M → $22.8M (-$4.58M)

Holders
70
Holders Change
+3
Holders Change %
+4.48%
% of All Funds
0.85%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
19
Increased
17
Reduced
15
Closed
13
Calls
$1.94M
Puts
$991K
Net Calls
+$950K
Net Calls Change
-$1.44M

Top Buyers

Rank Fund Capital Flow
1
Vanguard Group
Vanguard Group
Pennsylvania
+$2.34M
2
DnB Asset Management
DnB Asset Management
Norway
+$1.03M
3
BlackRock
BlackRock
New York
+$897K
4
Geode Capital Management
Geode Capital Management
Massachusetts
+$636K
5
6CM
683 Capital Management
New York
+$606K

Top Sellers

Rank Fund Capital Flow
1
HCM
Heights Capital Management
California
-$2.69M
2
EI
EAM Investors
California
-$632K
3
Millennium Management
Millennium Management
New York
-$90K
4
TRCT
Tower Research Capital (TRC)
New York
-$83K
5
EFI
EHP Funds Inc
Canada
-$77.6K
Name Holding Trade Value Shares
Change 		Change in
Stake
Carson Wealth (CWM LLC)
51
Carson Wealth (CWM LLC)
Nebraska
$5K – – –
Royal Bank of Canada
52
Royal Bank of Canada
Ontario, Canada
$4K – – –
AW
53
Avion Wealth
Texas
$3K +$1.18K +500 +50%
SPIA
54
Steward Partners Investment Advisory
New York
$2.6K – – –
TRCT
55
Tower Research Capital (TRC)
New York
$2.12K -$83K -35,055 -97%
AAP
56
Arax Advisory Partners
Colorado
$1.38K +$905 +382 +125%
LSA
57
Leonteq Securities AG
Switzerland
$1.32K – – –
EWA
58
EverSource Wealth Advisors
Alabama
$714 – – –
CA
59
Clearstead Advisors
Ohio
$550 +$651 +275 New
AF
60
Allworth Financial
California
$260 – – –
SWM
61
SHP Wealth Management
Massachusetts
$100 +$118 +50 New
S
62
SignatureFD
Georgia
$36 – – –
FDCDDQ
63
Federation des caisses Desjardins du Quebec
Quebec, Canada
$2 -$3.32K -1,400 -100%
Fidelity Investments
64
Fidelity Investments
Massachusetts
$2 -$734 -310 -100%
AUB
65
Atlantic Union Bankshares
Virginia
$2 – – –
EPIMS
66
Evelyn Partners Investment Management Services
$2 – – –
FS
67
Financially Speaking
Colorado
$2 – – –
Jones Financial Companies
68
Jones Financial Companies
Missouri
$2 – – –
WWM
69
Wolff Wiese Magana
California
$2 – – –
HI
70
Harbour Investments
Wisconsin
$2 +$2 +1 New
HCM
71
Heights Capital Management
California
– -$2.69M -883,104 Closed
EI
72
EAM Investors
California
– -$632K -207,322 Closed
EFI
73
EHP Funds Inc
Canada
– -$77.6K -25,445 Closed
Group One Trading
74
Group One Trading
Illinois
– -$44.1K -18,625 Closed
OAM
75
Oxford Asset Management
United Kingdom
– -$54K -17,694 Closed
1 2
3
4

MBOT Hedge Fund Activity: Q4 2025 in Review

70 of the 8,228 institutional investors tracked by Wall St. Rank reported a position in Microbot Medical (MBOT) for Q4 2025, worth a combined $22.8M — down 17% from $27.4M a quarter earlier.

Buyers outnumbered sellers: 19 funds opened new MBOT positions and 13 closed out — a net gain of 6 holders — while 17 added to existing stakes and 15 trimmed.

The largest buyer was Vanguard Group, adding an estimated $2.34M. The largest seller was Heights Capital Management, exiting entirely with an estimated $2.69M sold.

  • 70 institutional investors held Microbot Medical (MBOT) as of Q4 2025, up from 67 in Q3 2025.
  • Funds reported $22.8M of Microbot Medical stock for Q4 2025, down 17% quarter-over-quarter.
  • 19 funds opened new Microbot Medical positions in Q4 2025 and 13 closed out, a net change of +6 holders.
  • The largest Microbot Medical buyer in Q4 2025 was Vanguard Group, an estimated $2.34M added.
  • The largest Microbot Medical seller in Q4 2025 was Heights Capital Management, an estimated $2.69M sold.

Based on aggregated 13F filings for Q4 2025.